Volume 14, Issue 53 (12-2023)                   NCMBJ 2023, 14(53): 9-20 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Asghari Lalemi Z, Tafvizi F, Naseh V, Salehipour M. Expression changes of apoptotic and metastatic genes in MCF-7 and SKBR3 breast cancer cells under the influence of niosomes containing farnesol and gingerol. NCMBJ 2023; 14 (53) :9-20
URL: http://ncmbjpiau.ir/article-1-1644-en.html
Department of Biology, Parand Branch, Islamic Azad University, Parand, Iran , farzanehtafvizi54@gmail.com
Abstract:   (284 Views)
Aim and Background:Farnesol and gingerol are two powerful plant active ingredients that have proven anti-cancer and antioxidant effects. In this study, the expression changes of Caspase 8, Matrix metalloproteinases 2, Matrix metalloproteinases 9 and Vascular endothelial growth factor genes were studied in MCF-7 and SKBR3 cancer cell lines treated with niosomes containing farnesol and gingerol.
Material and Methods: MCF-7 and SKBR3 cells were treated with niosome containing farnesol and gingerol, combination of two drugs, single drug niosome formulation and free drug for 48 hours. Gene expression changes were investigated using Real-Time PCR technique and statistical analysis was done at 0.05 level with GraphPad Prism software.
Results: Niosome codelivery containing two drugs (N-Far/Gin) caused a significant increase in the level of caspase 8 gene expression and also a significant decrease in the regulation of the expression of Matrix metalloproteinases 2, Matrix metalloproteinases 9, and Vascular endothelial growth factor genes (P<0/001). It had a higher significance level than the treatment with other formulations.
Conclusion: It seems that farnesol and gingerol-loaded niosomes have great anti-apoptotic, anti-metastatic, and anti-angiogenic potential in the prevention of breast cancer. Further in vivo experiments and clinical studies can elucidate the potential of N-Far/Gin to be applied as a medicinal agent in breast cancer treatment.



 
Full-Text [PDF 503 kb]   (57 Downloads)    
Type of Study: Research Article | Subject: Physiology
Received: 2023/01/15 | Accepted: 2023/02/20 | Published: 2023/12/22

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb